Article
news head

June 20, 2016

A new noninvasive monitoring test for bladder cancer

Nucleix is making a simple urine test to monitor the disease, which has the highest lifetime treatment cost per patient of all types of cancer.

read more >

Article
news head

June 14, 2016

11 Early-Stage Healthcare Companies To Watch At BIO 2016

With the BIO 2016 healthcare conference in San Francisco coming up June 6 to June 9, we used the CB Insights database to highlight a few early-stage companies exhibiting that are tackling interesting problems. We scraped the exhibitor page on

read more >

Article
news head

May 24, 2016

Israeli cancer detection co Nucleix raises $3m

The company’s first test for the detection of bladder cancer could be available in Europe within a couple of months. Israeli cancer detection company Nucleix has raised $3 million from Morris Kahn’s Aurum Ventures MKI, OrbiMed Israel Partners, and Zohar

read more >

Press Release
news head

April 25, 2016

Nucleix Bladder EpiCheck Abstract to be Featured in a Poster Discussion Session at the 2016 AUA (American Urological Association) Annual Meeting on May 2016 in San Diego

Rehovot, Israel, April 24th 2016 – Nucleix, an innovative epigenetic cancer detection and screening company, announced today that the results of their latest Bladder EpiCheck study will be presented as a poster presentation in the next annual meeting of the

read more >

Press Release
news head

April 21, 2016

Nucleix Welcomes Dr. Heiner Dreismann as a New Member to the Board of Directors

Rehovot, Israel, April 21, 2016 – Nucleix, an innovative epigenetic cancer detection and screening company, announced today that Dr. Heiner Dreismann, a seasoned executive and industry expert, has joined the company?s board of directors. ?As the previous CEO of Roche

read more >

Article
news head

March 22, 2016

Nucleix Won an EU Horizon 2020 Grant and Appeared in the Research*EU Magazine

Nucleix received a grant from the European Commission as part of the Horizon 2020 SME Instrument Phase I, under grant agreement number 696425. The grant was given to support the commercial development of lung cancer and colorectal cancer screening products

read more >

Press Release
news head

March 20, 2016

Nucleix Introduced Bladder EpiCheck in the European Association of Urology (EAU) Annual Meeting

Nucleix presented Bladder EpiCheck during the annual meeting of the European Association of Urology (EAU), to expose more than 12,000 urology professionals to the upcoming launch of Bladder EpiCheck in the EU. The meeting took place in Munich during March

read more >

Article
news head

June 16, 2014

Cancer screening company Nucleix raises $5m

Orbimed Israel and Zohar Zisapel participated in the financing round. Nucleix, which is developing a test for early detection of bladder cancer, has raised more than $5 million in an investment round led by venture capital firm OrbiMed Advisors LLC.

read more >